Photys Therapeutics
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $38M
Investors
- 10
About Photys Therapeutics
Based in Massachusetts, US, and founded in 2021 by Amit Choudhary, Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, Wendy Young, and Eric Fischer, Photys Therapeutics is a pharmaceutical research and development company involved in the development of phosphorylation-inducing chimeric small molecule medicines (PHICS). The company's patented platform targets disease proteins and enhances endogenous disease-fighting mechanisms, repairs signaling, and restores protein function to treat a variety of diseases, including cancer, immune, metabolic, and rare diseases. Small molecules are used to unlock finely tuned control of post-translational modifications of proteins.
Who invested in Photys Therapeutics
10 investors across 1 round
See all investors in Photys Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 16, 2021
Amount
$38M
Investors
Questions about Photys Therapeutics
Who invested in Photys Therapeutics?
Photys Therapeutics has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Photys Therapeutics raised?
Photys Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Photys Therapeutics last raise money?
Photys Therapeutics's most recent round on record is a Series A, in Dec 2021.
What does Photys Therapeutics do?
Based in Massachusetts, US, and founded in 2021 by Amit Choudhary, Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, Wendy Young, and Eric Fischer, Photys Therapeutics is a pharmaceutical research and development company involved in the development of phosphorylation-inducing chimeric small molecule medicines (PHICS).
Where is Photys Therapeutics headquartered?
Photys Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Photys Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Photys Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Photys Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.